OLYMY (Olympus) Short-Term Debt: $503 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OLYMY Olympus Corp OLYMY
77 GF Score
Price $10.77
GF Value $16.71
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Olympus Short-Term Debt?

Olympus OLYMY -1.64% 77 Short-Term Debt is $503 Mil as of Mar. 2026. GuruFocus rates OLYMY with a GF Score™ of 77/100 and a GF Value™ of $16.71 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Olympus's Short-Term Debt for the quarter that ended in Mar. 2026 was $503 Mil.

Olympus's quarterly Short-Term Debt increased from Sep. 2025 ($0 Mil) to Dec. 2025 ($501 Mil) and increased from Dec. 2025 ($501 Mil) to Mar. 2026 ($503 Mil).

Olympus's annual Short-Term Debt increased from Mar. 2024 ($467 Mil) to Mar. 2025 ($637 Mil) but then declined from Mar. 2025 ($637 Mil) to Mar. 2026 ($503 Mil).

Olympus Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Olympus Short-Term Debt Related Terms

Olympus Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Olympus's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olympus Short-Term Debt Chart

Olympus Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 440.90 373.85 467.15 637.24 503.37

Olympus Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 637.24 311.44 0.00 501.44 503.37
OLYMY
77GF Score
Olympus Corp OLYMY
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $503 Mil mean?
Olympus (OLYMY) has a Short-Term Debt of $503 Mil as of Mar. 2026.
Is Olympus' Short-Term Debt too high?
Olympus' current Short-Term Debt is $503 Mil. Overall, Olympus has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olympus' Short-Term Debt compare to ABT and SYK?
Olympus' Short-Term Debt of $503 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Olympus's current Short-Term Debt is $503 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olympus stock overvalued right now?
Based on GuruFocus' analysis, Olympus (OLYMY) is currently considered Significantly Undervalued. The stock's GF Value™ is $16.71, compared to a current price of $10.77 — trading 35.5% below its estimated fair value. The current Short-Term Debt is $503 Mil. Olympus' overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Olympus (OLYMY), the current Short-Term Debt is $503 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Olympus (OLYMY) Overvalued in 2026?

Based on GuruFocus' analysis, Olympus stock appears to be undervalued. The current stock price of $10.77 is trading 35.5% below its estimated GF Value™ of $16.71. GuruFocus considers Olympus to be Significantly Undervalued.

Key valuation signals for OLYMY:

  • Short-Term Debt: $503 Mil
  • GF Value™: $16.71 vs. price of $10.77 (35.5% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the OLYMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Olympus Business Description

Address 2951 Ishikawacho, Hachioji, JPN, 192-8507
Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
77GF Score

Get the complete analysis for OLYMY

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.77
Price
$16.71
GF Value